Akela Pharma Inc. — Investor Relations & Filings

Akela Pharma Inc. is an integrated drug development company focused on creating therapeutics for the pain and inhalation markets. The company leverages proprietary drug delivery technologies to develop pharmaceutical preparations targeting disorders of the respiratory and central nervous systems. A significant operational component is PharmaForm, a wholly owned subsidiary. PharmaForm functions as a specialty contract service provider, offering comprehensive expertise in pharmaceutical dosage form development, formulation research and development, and related pre-clinical and clinical services. Key historical developments include the licensing of the Fentanyl TAIFUN(R) system. The company has strategically prioritized its profitable contract services division.